These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36139950)

  • 1. Characterization of Carbapenemase-Producing
    Főldes A; Oprea M; Székely E; Usein CR; Dobreanu M
    Antibiotics (Basel); 2022 Aug; 11(9):. PubMed ID: 36139950
    [No Abstract]   [Full Text] [Related]  

  • 2. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
    Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A
    Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Epidemiology of Carbapenem- and Colistin-Resistant
    Palmieri M; D'Andrea MM; Pelegrin AC; Mirande C; Brkic S; Cirkovic I; Goossens H; Rossolini GM; van Belkum A
    Front Microbiol; 2020; 11():294. PubMed ID: 32153554
    [No Abstract]   [Full Text] [Related]  

  • 4. Heteroresistance to Colistin in Clinical Isolates of
    Sánchez-León I; García-Martínez T; Diene SM; Pérez-Nadales E; Martínez-Martínez L; Rolain JM
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Six Phenotypic Assays with Reference Methods for Assessing Colistin Resistance in Clinical Isolates of Carbapenemase-Producing Enterobacterales: Challenges and Opportunities.
    Főldes A; Székely E; Voidăzan ST; Dobreanu M
    Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in two component system (PhoPQ and PmrAB) in colistin resistant Klebsiella pneumoniae from North Indian tertiary care hospital.
    Nirwan PK; Chatterjee N; Panwar R; Dudeja M; Jaggi N
    J Antibiot (Tokyo); 2021 Jul; 74(7):450-457. PubMed ID: 33820943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal dissemination of
    Bovo F; Amadesi S; Palombo M; Lazzarotto T; Ambretti S; Gaibani P
    JAC Antimicrob Resist; 2023 Aug; 5(4):dlad099. PubMed ID: 37600494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates.
    Lomonaco S; Crawford MA; Lascols C; Timme RE; Anderson K; Hodge DR; Fisher DJ; Pillai SP; Morse SA; Khan E; Hughes MA; Allard MW; Sharma SK
    PLoS One; 2018; 13(6):e0198526. PubMed ID: 29883490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin Resistance in Clinical Isolates of
    Conceição-Neto OC; da Costa BS; Pontes LDS; Silveira MC; Justo-da-Silva LH; de Oliveira Santos IC; Teixeira CBT; Tavares E Oliveira TR; Hermes FS; Galvão TC; Antunes LCM; Rocha-de-Souza CM; Carvalho-Assef APD
    Front Cell Infect Microbiol; 2022; 12():898125. PubMed ID: 35909953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KPC-2-producing Klebsiella pneumoniae ST147 in a neonatal unit: Clonal isolates with differences in colistin susceptibility attributed to AcrAB-TolC pump.
    Naha S; Sands K; Mukherjee S; Roy C; Rameez MJ; Saha B; Dutta S; Walsh TR; Basu S
    Int J Antimicrob Agents; 2020 Mar; 55(3):105903. PubMed ID: 31954832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant
    Shrief R; El-Ashry AH; Mahmoud R; El-Mahdy R
    Infect Drug Resist; 2022; 15():6203-6214. PubMed ID: 36324668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of carbapenemase-producing and colistin resistant Klebsiella pneumoniae ST101 high-risk clone in Turkey.
    Hazırolan G; Karagöz A
    Acta Microbiol Immunol Hung; 2020 Nov; 67(4):216-221. PubMed ID: 33174866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Epidemiology of Carbapenemase-Producing and Colistin-Resistant
    Legese MH; Asrat D; Mihret A; Hasan B; Mekasha A; Aseffa A; Swedberg G
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0053422. PubMed ID: 35876577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of a ST307 clone carrying a novel insertion element MITEKpn1 in the mgrB gene among carbapenem-resistant Klebsiella pneumoniae from Moscow, Russia.
    Shamina OV; Kryzhanovskaya OA; Lazareva AV; Alyabieva NM; Polikarpova SV; Karaseva OV; Mayanskiy NA
    Int J Antimicrob Agents; 2020 Feb; 55(2):105850. PubMed ID: 31770629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-occurrence of genes encoding carbapenemase, ESBL, pAmpC and non-β-Lactam resistance among Klebsiella pneumonia and E. coli clinical isolates in Tunisia.
    Ben Sallem R; Laribi B; Arfaoui A; Ben Khelifa Melki S; Ouzari HI; Ben Slama K; Naas T; Klibi N
    Lett Appl Microbiol; 2022 May; 74(5):729-740. PubMed ID: 35076956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on plasmids.
    Giordano C; Barnini S; Tsioutis C; Chlebowicz MA; Scoulica EV; Gikas A; Rossen JW; Friedrich AW; Bathoorn E
    Int J Antimicrob Agents; 2018 Feb; 51(2):260-265. PubMed ID: 29097338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307.
    Cejas D; Elena A; Guevara Nuñez D; Sevillano Platero P; De Paulis A; Magariños F; Alfonso C; Berger MA; Fernández-Canigia L; Gutkind G; Radice M
    J Glob Antimicrob Resist; 2019 Sep; 18():238-242. PubMed ID: 31202977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Insights into Colistin-Resistant Klebsiella pneumoniae from a Tunisian Teaching Hospital.
    Jaidane N; Bonnin RA; Mansour W; Girlich D; Creton E; Cotellon G; Chaouch C; Boujaafar N; Bouallegue O; Naas T
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First Clinical Cases of KPC-2-Producing
    Brahmia S; Lalaoui R; Nedjai S; Djahmi N; Chettibi S; Rolain JM; Bakour S
    Microb Drug Resist; 2021 May; 27(5):652-659. PubMed ID: 32991248
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.
    Hernández-García M; Castillo-Polo JA; Cordero DG; Pérez-Viso B; García-Castillo M; Saez de la Fuente J; Morosini MI; Cantón R; Ruiz-Garbajosa P
    J Clin Microbiol; 2022 Mar; 60(3):e0224521. PubMed ID: 35107303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.